RxTally.CA — Canadian maple leaf logoClarity in every comparison.
Drug approvals

Sandoz generic Ozempic approved in Canada: what comes next?

If you have been waiting for more generic Ozempic options, another manufacturer is worth knowing about: Sandoz. Its Canadian approval is confirmed, but that does not yet tell you whether your pharmacy can fill a prescription with this product—or what you would pay. Here is how to read the news without confusing an approval with a launch.

By RxTallyLast Update 5 min read

Key takeaways

  • Sandoz announced Canadian approval on September 18, 2026 for adult type 2 diabetes. This is September news, not a new October approval.
  • Health Canada lists two pen presentations: DIN 02571501 for 0.25 mg or 0.5 mg doses, and DIN 02571528 for 1 mg doses.
  • Both records showed Approved with a September 16 status date when checked on October 1. That status is distinct from Marketed.
  • The announcement does not establish a Canadian retail price, a pharmacy stock date or your insurance coverage.

What Sandoz actually announced

On September 18, Sandoz Canada announced authorization for Sandoz Semaglutide, its generic version of Ozempic, for adults with type 2 diabetes. The company described commercialization as a next step. It did not announce completed distribution to Canadian pharmacies.

For someone comparing medication costs, the useful takeaway is a new manufacturer to watch. It would be premature to put a Sandoz price into a household budget using another generic manufacturer’s quote.

Source: Sandoz Canada approval announcement · September 18, 2026

Two pens, two DINs: the details that distinguish them

DIN 02571501 identifies a multidose prefilled pen delivering 0.25 mg or 0.5 mg doses. DIN 02571528 identifies the presentation delivering 1 mg doses. Health Canada lists Sandoz Canada Incorporated as the company, semaglutide at 1.34 mg/mL as the ingredient strength, and subcutaneous injection as the route for both.

The concentration and the dose delivered are different pieces of information. The matching concentration does not make the two pens the same presentation. These details identify products; they are not instructions to choose a dose or change treatment.

If a pharmacy provides a quote, ask it to include the DIN and quantity. That gives you a specific product to compare instead of a price attached only to the broad label “generic semaglutide.”

Source: Health Canada: DIN 02571501 · 0.25/0.5 mg pen

Source: Health Canada: DIN 02571528 · 1 mg pen

Approved does not mean on the pharmacy shelf

Our October 1 check retrieved both Health Canada product records directly. Each displayed Approved and a current status date of September 16, 2026. That is the regulatory record date; September 18 is the manufacturer’s announcement date. Neither should be relabelled as an October approval because the news was discovered later.

Health Canada defines Approved as authorized for sale but not yet marketed. Marketed is a separate database status. Even a later change to Marketed would not establish stock at a particular pharmacy.

For a practical availability check, ask whether the pharmacist can order the exact DIN now, whether the supplier has confirmed it, and when it could be ready. A place on a waiting list is different from an order with a confirmed delivery date.

Source: Health Canada: DPD status definitions

What could this mean for the price you pay?

RxTally’s view: another approved supplier is a development worth following, but a promised saving needs a product-specific price behind it. The sources reviewed here do not provide a confirmed Sandoz pharmacy cash price. We therefore have no verified saving to calculate for this product.

When quotes become available, compare the same presentation, quantity and expected supply period. Ask for the medication cost and dispensing fee separately, then check whether delivery or clinical-service charges sit outside that total. A low starting price is less useful than a written total for the prescription you actually need.

Keep insurance as a separate question. Ask your plan to check the exact DIN and your eligibility rather than assuming that coverage for a brand or another generic carries over. Until those answers are available, leave the Sandoz price blank in your comparison instead of borrowing a number from a different product.

Is this a generic Wegovy approval?

No. Sandoz’s announcement identifies Ozempic as the reference product and adult type 2 diabetes as the approved use. It should not be presented as an announcement of a Wegovy-reference generic for weight management.

For readers arriving from a weight-loss price comparison, that distinction matters. Bring the exact product name to your prescriber or pharmacist and ask how it relates to your existing prescription. This article does not recommend switching products or using a medication for a particular condition.

The next milestone to watch

For a useful update, look for a dated commercial-launch announcement, a change in the product’s regulatory status, or an identifiable pharmacy quote. Each answers a different question. Keeping evidence beside each milestone makes it easier to see what has changed and what still needs confirmation.

A submissions-under-review list is useful for following applications, but it is not a complete account of every approved product. Here, the approval announcement and the two DIN records provide the relevant evidence. A review-list snapshot should not override those product-specific records.

If you contact a pharmacy, three questions will keep the conversation focused: Can you obtain this DIN? What is the total for my prescribed quantity? What will my plan pay? Those answers will make the next Sandoz update more useful than an approval headline alone.

Frequently asked questions

When was Sandoz Semaglutide approved in Canada?

The two Health Canada records show an Approved status dated September 16, 2026. Sandoz announced the authorization on September 18. October 1 is RxTally’s source-check date, not a new approval date.

Can I buy Sandoz generic Ozempic at a pharmacy now?

The records checked for this article do not establish pharmacy availability. They showed Approved, and the September announcement described a forthcoming commercial launch. Ask your pharmacist to confirm current ordering and stock for the exact DIN.

How much will Sandoz Semaglutide cost?

No confirmed pharmacy price was established from the sources reviewed. Prices for other semaglutide products should not be presented as Sandoz quotes.

Which DIN should I ask the pharmacist about?

02571501 identifies the pen delivering 0.25 mg or 0.5 mg doses; 02571528 identifies the 1 mg-dose pen. Your pharmacist should match the product to your prescription. These identifiers are not dosing advice.

Sources & further reading

Related reading